Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
User

Kahn Brothers Group recent buys & sells (2015 Q1)

Thomas Graham, Alan, Irving Kahns

Kahn Brothers Group Portfolio Changes

Purchase & sale details

Portfolio value:
$592.07M (+$12M)
Previous value:
$580.19M
# of changes:
33
New positions:
0
Reported for:
31 Mar 2015 (Q1)
Latest filing date:
06 May 2015
Kahn Brothers Group has disclosed a total of 33 changes to the portfolio in the (2015 Q1) SEC report(s): increased the number of shares of 4, decreased the number of shares of 27 and completely sold out 2 position(s).

What stocks did Kahn Brothers Group buy in 2015 Q1?

During 2015 Q1 Kahn Brothers Group has purchased 4 securities: (BP) BP PLC-SPONS ADR (added shares +4.54%), (BB) BlackBerry Ltd (added shares +27.82%), (PTEN) Patterson-UTI Energy Inc (added shares +10.02%) and (GSK) GlaxoSmithKline PLC ADR (added shares +14.12%).

What did Kahn Brothers Group invest in during 2015 Q1?

Kahn Brothers Group's top 5 holdings (by % of portfolio) were (PFE) Pfizer Inc (10.64%), (MRK) Merck & Company Inc (10.00%), (C) Citigroup Inc (9.84%), (NYT) New York Times Company (9.30%) and (FLG) Flagstar Financial, Inc (9.15%).
In the 2015 Q1 report(s) the following changes have been made to the top investments: (PFE) Pfizer Inc (reduced shares -3.83%), (MRK) Merck & Company Inc (reduced shares -2.18%), (C) Citigroup Inc (reduced shares -4.99%), (NYT) New York Times Company (reduced shares -3.12%) and (FLG) Flagstar Financial, Inc (reduced shares -4.14%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".